236 results on '"Pardi, Norbert"'
Search Results
2. Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth
3. Author Correction: A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax
4. mRNA vaccination of rabbits alters the fecundity, but not the attachment, of adult Ixodes scapularis
5. The roles of CD4+ T cell help, sex, and dose in the induction of protective CD8+ T cells against a lethal poxvirus by mRNA-LNP vaccines
6. mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies
7. A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax
8. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
9. Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction
10. Molecular fate-mapping of serum antibody responses to repeat immunization
11. Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
12. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
13. Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
14. Evaluation of the immunogenicity of an mRNA vectored Nipah virus vaccine candidate in pigs
15. Enhancing prime editor activity by directed protein evolution in yeast
16. Single cell phototransfection of mRNAs encoding SARS-CoV2 spike and nucleocapsid into human astrocytes results in RNA dependent translation interference
17. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
18. Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier
19. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
20. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
21. Expression and purification of the receptor‐binding domain of SARS‐CoV‐2 spike protein in mammalian cells for immunological assa
22. Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
23. Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
24. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
25. Author Correction: Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
26. Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
27. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
28. Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria
29. Expression and purification of the receptor‐binding domain of SARS‐CoV‐2 spike protein in mammalian cells for immunological assays.
30. VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis
31. Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models
32. Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
33. Progress in vaccine development for infectious diseases : a Keystone Symposia report
34. Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination
35. Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
36. Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
37. Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury
38. A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets
39. Graft-Versus-Host Disease Induces Immune Dysregulation through Irreversible Damage to Specialized Immune-Interacting Fibroblastic Stromal Cells in Secondary Lymphoid Organs
40. A minimally-edited mouse model for infection with multiple SARS-CoV-2 strains
41. Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
42. Innate immune mechanisms of mRNA vaccines
43. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
44. A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets
45. A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets
46. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
47. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine
48. mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice
49. Nucleoside-Modified mRNA Vaccines Protect IFNAR –/– Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
50. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.